Accenture (ACN) Dips More Than Broader Markets: What You Should Know
Accenture PLC Cl A Stock Falls Friday, Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Accenture PLC Cl A (ACN) slipped 1.66% to $289.22 Friday, on what proved to be an all-aroun
Jefferies Financial Group Weighs in on Accenture Plc's Q1 2024 Earnings (NYSE:ACN)
Accenture plc (NYSE:ACN – Get Rating) – Equities researchers at Jefferies Financial Group cut their Q1 2024 earnings estimates for Accenture in a report released on Wednesday, February 1st. Jeffer
Accenture PLC Cl A Stock Outperforms Market On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Accenture PLC Cl A (ACN) rose 3.70% to $294.10 Thursday, on what proved to be an all-around
Accenture Acquires Bionest For Undisclosed Sum
11:29 AM EST, 02/02/2023 (MT Newswires) -- Accenture (ACN) said Thursday that it has acquired consulting firm Bionest for an undisclosed sum. The Bionest team will join Accenture Strategy in the Life
Accenture Acquires Strategy and Consulting Firm Bionest
Accenture Expands Strategy Capabilities In Life Sciences With The Acquisition Of Bionest >ACN
Accenture Expands Strategy Capabilities in Life Sciences With the Acquisition of Bionest
Accenture (NYSE:ACN) has acquired Bionest, a strategy and consulting firm dedicated to addressing complex strategic decisions for leading biopharma organizations across innovative areas of science including precision
Cloud-based Solutions for Drug Discovery Market Size to Hit US$ 8.04 Billion by 2030 | IBM Corporation, Accenture PLC, Oracle Corporation, Amazon Web Services, Inc., NVIDIA Corporation
Singapore, Feb. 02, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled, "Cloud-Based Solutions For Drug Discovery Market by Service Type (IaaS, PaaS, SaaS), End User (Pharmaceuticals,
Accenture Plc (NYSE:ACN) Is Pegasus Asset Management Inc.'s 7th Largest Position
Pegasus Asset Management Inc. reduced its position in shares of Accenture plc (NYSE:ACN – Get Rating) by 1.2% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 17,924 sh
Loading...
No Stock Yet